Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR
Authors:
- Collaborative Study Group of Scientific Research of the Japanese Breast Cancer SocietyCSCollaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
- Makoto IshitobiMIMakoto Ishitobi
- Atsushi YoshidaAYAtsushi Yoshida
- Tadahiko ShienTadahiko Shien
- 13 March 2013
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer
- Vol. 21 (6) , 754-760
Abstract
There are limited data on the outcomes of patients treated with repeat lumpectomy at the time of ipsilateral breast tumor recurrence (IBTR). Especially, the impact of radiotherapy (RT) on a second IBTR is unknown. We retrospectively analyzed 143 patients from 8 institutions in Japan who underwent repeat lumpectomy after IBTR. The risk factors of a second IBTR were assessed. The median follow-up period was 4.8 years. The 5-year second IBTR-free survival rate was 80.7 %. There was a significant difference in the second IBTR-free survival rate according to RT (p = 0.0003, log-rank test). The 5-year second IBTR-free survival rates for patients who received RT after initial surgery, RT after salvage surgery, and no RT were 78.0, 93.5, and 52.7 %, respectively. Multivariate analysis revealed that RT was a significantly independent predictive factor of second IBTR-free survival. Repeat lumpectomy plus RT is a reasonable option in patients who did not undergo RT at the initial surgery. In contrast, caution is needed when RT is omitted in patients who have undergone repeat lumpectomy.Keywords
This publication has 16 references indexed in Scilit:
- Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best CandidatesAnnals of Surgical Oncology, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Omission of radiation therapy after breast‐conserving surgery in the United StatesCancer, 2011
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancerExperimental and Therapeutic Medicine, 2010
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20Journal of Clinical Oncology, 2010
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI: Journal of the National Cancer Institute, 2009
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinomaEuropean Journal of Surgical Oncology, 2006
- Is breast conservation after local recurrence feasible?European Journal of Cancer and Clinical Oncology, 1991